好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Prospective Assessment of End of Life Symptoms and Quality of Life in Glioblastoma
Neuro-oncology
P6 - (-)
153
Authors/Disclosures
Tobias Walbert, MD, PhD, FAAN (Henry Ford Hospital Detroit)
PRESENTER
Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion .
Lonni Schultz, PhD (Henry Ford Hospital) Dr. Schultz has nothing to disclose.
Joel N. Phillips, DO, FAAN (Trinity Health Physician Partners) Dr. Phillips has nothing to disclose.